The company and one of its subsidiaries would allegedly confuse clinicians and have them bill government programs for cardiac monitoring services that were more expensive than what they needed. This settlement resolves those allegations.
“We write to emphasize the urgent need for Congress to take action," the Medical Group Management Association wrote to House and Senate leaders Dec. 19.